|
|
|
|
|
|
|
27.02.26 - 12:36
|
Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters′ Option to Purchase Additional Shares (Business Wire)
|
|
|
HENDERSON, Nev.--(BUSINESS WIRE)--$ZURA #TeamZura--Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating autoimmune and inflammatory diseases, today announced that it closed its previously announced underwritten public offering of Class A ordinary shares and pre‑funded warrants on February 26, 2026.
The offering consisted of 21,200,000 Class A ordinary shares priced at $6.25 per share, along with pre‑funded warrants for 1,800,000 Class A ordinary shares priced at $6.249 per warrant, which included 3,000,000 additional Class A ordinary shares sold upon exercise in full by the underwriters of their option to purchase additional shares of stock in the offering. All shares and pre-funded warrants were sold by Zura.
Gross proceeds from the offering were approximately $144 million, before deducting underwriting discounts and commissions and other offering e...
|
|
|
|
|
|
|
|
|
27.02.26 - 06:15
|
Research: M Stanley's H-shr Focus List (Table) (AAStocks)
|
|
|
Stocks | Potential Upside from Target PricesAlibaba (BABA.US) | 17.8%CHALCO (601600.SH) | +20.7%CATL (300750.SZ) | 33.3%DUALITYBIO-B (09606.HK) | 41.8%ESPRESSIF (688018.SH)| 30.7%HKEX (00388.HK) | 22%HKT-SS (06823.HK) | 7.1%NARI (600406.SH) | 0.9%PING AN (02318.HK) | 22.6%INOVANCE TECH (300124.SZ) | 25.7%SINOMA SCI & TECH (0......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
